Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors

Figure 5

GFAP+NNP vs. GBM neural differentiation. a, GFAP+NNP cells at passage 1, three days of neural differentiation. Cells positive for CD44 and GFAP, and cells positive for MAP2 and GFAP but negative for CD44. MAP2 dominates but GFAP is visible. Cells CD44+, GFAP+ are also presented. b, GFAP+NNP cells at passage 1, four days of neural differentiation. Two types of cells are visible: positive for CD44 and GFAP, and cells MAP2+; GFAP+, CD44-. c, GFAP+NNP cells at passage 1, 5 days of neural differentiation: GFAP+ MAP2- and MAP2+ GFAP- cells. d, GBM2: CD44, GFAP, MAP2 positive cells- cells sustaining discordant phenotype. e, GBM 1 cells released from aggregate, 15 days of neural differentiation: cells GFAP- MAP2- and MAP2+ GFAP+ are visible. f, GBM3: CD44 negative, GFAP and MAP2 positive cells in the centre. g, GBM8: strongly MAP2 positive cells and GFAP, CD44 positive cells released from the aggregate. h, GBM4: GFAP and MAP2 positive cells sustaining Nestin expression.

Back to article page